NIH SBIR funding from the National Heart, Lung, and Blood Institute advances the secure data platform behind a wearable designed to ease the burden of manual vital-signs checks and to support better-informed care whether in the hospital or at home.Continue reading
Category Archives: AZBio News
Xcellerant Ventures Invests $1M in Geneticure to Advance Precision Medicine and Expand Arizona’s Biotech Hub
Precision medicine pioneer to establish new clinical lab in Arizona, bringing predictive testing for renal denervation to marketContinue reading
Announcing the 2026 AZBio Trailblazers
Each year, AZBio looks back across the legislative session to identify those leaders whose actions and active engagement support the growth of Arizona’s life science and healthcare industry and help to ensure the people of Arizona benefit from its success. Scores are then tallied and the top ten legislative leaders are named the year’s Trailblazers.
The Arizona Bioindustry Association (AZBio) will honor Arizona Legislators on December 10, 2026 for their service to the community and for championing research, education, innovation, the growth of Arizona’s bioscience sector, and for ensuring that Arizona patients benefit from life science innovation.
PathogenDx Announces Five-Year Cooperative Research and Development Agreement with USDA Agricultural Research Service, to Advance Rapid Detection of High-Pathogenicity Salmonella
- PathogenDx Announces Five-Year Cooperative Research and Development Agreement with USDA Agricultural Research Service, to Advance Rapid Detection of High-Pathogenicity Salmonella
- Research collaboration will integrate Salmonella virulence-associated gene targets into PathogenDx’s SeroX D3 Array platform, with applications spanning poultry, pork and beef
President Trump Signs Historic Executive Order to Advance Women’s Health, Championed by First Lady Melania Trump
WASHINGTON, D.C.—OCTOBER 19, 2026—President Donald J. Trump, with the leadership and support of First Lady Melania Trump, today signed an executive order, Advancing Women’s Health to Improve Outcomes in All Phases of Life, which directs the U.S. Department of Health and Human Services (HHS) to establish a new Women’s Health Division within the National Institutes of Health (NIH) to strengthen scientific research, accelerate medical breakthroughs, and improve health outcomes for American women and girls.Continue reading
FDA-SEC Issues Memorandum of Understanding. How Does this Change their Information Sharing and What Does the Future Hold for Life Science Companies?
On August 31, 2026, the U.S. Food and Drug Administration (FDA) and the U.S. Securities and Exchange Commission (SEC) entered a Memorandum of Understanding (MOU) to enhance cooperation in their regulatory and enforcement responsibilities to improve market oversight and compliance.Continue reading
BioLab Holdings Launches EmeraNova™ to Advance the Future of Tissue Restoration
Expanded vision reflects focus beyond wound care to advancing innovation across the full tissue restoration journey Continue reading
FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Development Effort begins by Soliciting Public Feedback
The U.S. Food and Drug Administration, a division within the U.S. Department of Health and Human Services (HHS), today announced the Rare Disease Framework Initiative to reimagine the development of drugs and biologics for rare diseases. As outlined in a new white paper, the Initiative will develop an optimized, fit-for-purpose framework that reflects the realities of rare disease drug development by considering the nuances of each disease, patient needs, product type and the evidence that can be realistically generated in small patient populations.
Continue reading
Tesoro VC announces Frontier Forum in partnership with the City of Phoenix
Global startups advancing AI chips, robotics, quantum computing, biotechnology, dual-use and defense technologies to join a planned gathering of 300 founders, investors and industry leaders in PhoenixContinue reading
Study identifies protein signature that could help detect advanced fibrosis in liver disease
Extracellular vesicles offer a more precise window into liver injury than traditional blood testsContinue reading